BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Faecal microbiota transplantation (FMT, stool transplantation): Risk of transmission of multi-resistant bacteria

Active substance: FMT

The American Food and Drug Administration (FDA) warns of the risk of serious bacterial infections caused by the transmission of multi-resistant bacteria during faecal microbiota transplants (FMT).

To the risk information full text (available in German only)